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Silica particles with a quercetin–R5 peptide
conjugate are taken up into HT-29 cells and
translocate into the nucleus†
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Intracellular delivery of bioactive polyphenols is currently evaluated
as a protective strategy for cells under pharmaceutical stress. To this
end, the 20mer R5 peptide from the marine diatom C. fusiformis was
N-terminally modified with a quercetin derivative. This polyphenol–
peptide conjugate was used to generate homogeneous silica parti-
cles under biomimetic conditions that are efficiently taken up by
eukaryotic cells without being cytotoxic. However, not only was
accumulation in the cytoplasm of living cells observed via electron
and fluorescencemicroscopy but also translocation into the nucleus.
The latter was only seen when the quercetin–peptide conjugate was
present within the silica particles and provides a novel targeting
option for silica particles to nuclei.
Delivering biological cargo into cells is a complex process that
is diﬃcult to control and recent studies have taken advantage
of mesoporous silica nanoparticles as a suitable delivery tool.1,2
Here we focused on a biomimetic strategy to generate silica
particles that is based on the naturally occurring peptide R5
found in the marine diatom C. fusiformis.3 This 20mer peptide
generates, under biomimetic conditions, homogeneous sphe-
rical silica particles (SiPs). Alterations to the peptide structure
and sequence, e.g. by adding posttranslational modifications or
by shuﬄing the amino acid sequence, can lead to diﬀerent
particle morphologies.4,5 We have previously demonstrated that
peptide and protein cargo can be eﬃciently encapsulated into
the resulting silica particles without aﬀecting their function.6,7
Together with our current findings that hydrophobic N-terminal
modifications of the R5 sequence support self-assembly of the
peptide prior to silica precipitation,8 this has led us to generate a
covalent conjugate of a bioactive polyphenol, namely quercetin,
with the R5 peptide (Fig. 1A–C). Quercetin is a common dietary
polyphenol, also widely used as food supplement.9 Even if well-
known and characterized, thanks to its strong biological activity,
quercetin is of continuously rising scientific interest.10–12
For introducing a carboxylic acid linker into quercetin with-
out aﬀecting its function we chose to address the 7-hydroxy
group. This was achieved by first completely acetylating quer-
cetin with an excess of acetic anhydride in pyridine at 70 1C. It
was then regioselectively deprotected with imidazole and thio-
phenol in NMP as described by Kim et al. to give the 7-O-
monodeacetylated product.13 Subsequently, the carboxylic acid
linker was introduced by addition of ethyl iodoacetate. The
intermediate 3 was then deprotected using hydrochloric acid in
refluxing acetone as described by Mattarei et al. (11% yield over
4 steps, Fig. 1A).14 Coupling to the 20mer R5 peptide was
performed on resin prior to cleavage and purification (Fig. 1B).
The cleaved conjugate was then purified by RP-HPLC (Fig. 1C).
The resulting quercetin–R5 conjugate was dissolved at 1 mgml1
concentration in phosphate buffer at pH 7 and freshly generated
silicic acid was added to give highly homogeneous silica particles
with a peptide loading of 495%. Particles were separated by
centrifugation, washed and imaged by scanning electron micro-
scopy (SEM, Fig. 1D). The obtained particles were spherical with
a diameter ofB400 nm. Release of the conjugate from the silica
particles in 50 mM potassium phosphate buffer at neutral pH
and pH 4 was followed by UV-VIS spectroscopy, based on the
absorbance of quercetin at 375 nm. Here, a pH-dependent
release could be observed. At pH 4, 45% of the quercetin–R5
conjugate was found in the supernatant after 5 h, whereas at
neutral pH only 10% were released after 5 h and no further
increase in released conjugate was observed (Fig. 1F).
Therefore, quercetin–R5 containing SiPs were incubated in
aqueous buffer at pH 7.4 before incubation with cells for 5 h to
remove loosely associated quercetin–R5. To investigate the
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morphology of the particles after release of a large fraction of the
conjugate, a sample of the particles was incubated for 4.5 h in
50 mM phosphate buffer at pH 4. The particles were then
imaged by SEM showing that they retained their spherical shape
(Fig. 1E). The supernatant of the particles after 10 h incubation
at pH 4 was also analysed by LC-MS and clearly indicated that
the released conjugate was fully intact (Fig. S1, ESI†).
To test uptake of R5-based silica particles, human colon
adenocarcinoma HT-29 cells were cultivated and incubated with
R5-silica particles not containing quercetin. High-angle annular
dark-field scanning transmission electron microscopy (HAADF-
STEM) experiments on ultrathin cell sections were performed to
analyse intact cells and locate SiPs. Biomimetic SiPs show strong
bright contrast in HAADF-STEM images and appear to accumu-
late at the cellular membrane already after 1 h of incubation with
HT-29 cells (Fig. 2A). Accordingly, after 24 h of incubation
massive accumulation of SiPs in the intracellular compartment
but not in the nucleus was observed (Fig. 2B). Once we verified
that biomimetic R5-SiPs can enter the intracellular compart-
ment, a fluorescent variant was used in combination with live
cell imaging to follow the kinetic of uptake at the cellular level.
The fluorescein-labeled silane triethoxysilyl fluorescein was
incorporated into SiPs at a ratio of 1 to 20 to the R5 peptide.15
Similarly, a progressive uptake was observed that led to accu-
mulation of the fluorescent SiPs in the cytoplasm of HT-29 cells
after 3 h (Fig. 2C and D). Cytotoxicity measurement revealed no
toxicity of biomimetic SiPs in HT-29 cells (Fig. S2, ESI†).16
After demonstrating uptake of R5-SiPs into HT-29 cells
without detectable eﬀects on cell viability, we moved on to
quercetin–R5-based SiPs. These SiPs behaved similarly to the
R5– and fluorescein–R5-SiPs described above. Interestingly, we
noticed that the intrinsic fluorescence of the quercetin–R5
peptide, even when incorporated in SiPs, was sufficient for live
cell imaging (Fig. S3, ESI†). Concentration-dependent quercetin
fluorescence was measured in HT-29 cells to determine the
optimal concentration for live cell imaging (Fig. S4, ESI†).
Based on these results, in combination with cytotoxicity data
for R5 SiP, uptake experiments were performed at concentra-
tions of 70 mM quercetin or quercetin–R5 SiP, respectively.
The intrinsic fluorescence of the quercetin–R5 conjugate
allowed us to study uptake without any additional labelling,
which also excludes undesired effects of labels on the uptake
and targeting mechanisms. Here, uptake into HT-29 cells was
followed by live cell imaging and proved that already after 3 h a
major fraction of quercetin–R5 SiPs was found in cells (Fig. 3A–D).
However, uptake of quercetin–R5 SiPs starts immediately after
the application but it takes at least 90 min to reach the nucleus/
peri-nuclear region (Fig. S5, ESI†). In order to verify if the uptake
of quercetin–R5-SiPs was an active process or a consequence of
an alteration of the permeability of the cell membrane, respec-
tive live cell imaging experiments were performed (Fig. S6, ESI†).
Confocal live imaging microscopy allowed us to follow the uptake
of quercetin–R5 SiPs and subsequent interaction with the plasma
membrane (Fig. S6, ESI†). Uptake of the quercetin–R5 SiPs
Fig. 1 Quercetin–R5 conjugate. (A) Synthesis of modified quercetin (11% overall yield). Conditions: (I) Ac2O, pyridine, 70 1C; (II) imidazole, PhSH, NMP,
0 1C – rt; (III) DMF, Cs2CO3, ethyl iodoacetate, 0 1C rt; (IV) acetone, HCl, reflux; (B) quercetin modified R5 peptide; (C) analytical data of quercetin–R5
conjugate (RP-HPLC, ESI-MS) and SEM image of resulting silica particles before (D) and after (E) the release of the conjugate at pH 4, scale bars: 1 mm.
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occurred through active engulfment of the particles followed by
recovery of the membrane surface to its original integrity, thus
suggesting the SiPs uptake to be an active, energy-dependent
process and not a secondary effect of the particles sustained by a
loss of membrane integrity. These findings are supported by
uptake experiments at 4 1C and in the presence of wortmannin as
an inhibitor of phagocytosis/micropinocytosis17 and after treat-
ment with methyl-b-cyclodextrin (mbCD) to deplete cholesterol
and induce alterations of membrane organization and fluidity
(Fig. S7, ESI†).18 The uptake of quercetin–R5 SiPs was severely
reduced at 4 1C and SiPs are mainly found on the cell surface
after 3 h. However, as the wortmannin and mbCD treatment did
not lead to significant changes in uptake of quercetin–R5 SiPs,
we can currently only exclude the related uptake mechanisms of
phagocytosis/micropinocytosis and caveolin-mediated endocyto-
sis for HT-29 cells. Moreover, the quercetin-modified SiPs accu-
mulated inside the nucleus (Fig. 3E and F and cross sections of
the cell surface/central section), a behaviour not observed for any
other SiPs investigated here and rarely for silica (nano-) particles
tested in other studies.19,20
To control if this targeting eﬀect was accompanied by a
biological eﬀect, comet assay (single cell gel electrophoresis)
experiments were performed with the quercetin–R5 SiPs in
comparison to the corresponding concentration of quercetin
(70 mM), quercetin–R5 and R5 SiPs. Interestingly, binding of
quercetin to SiPs abolished the genotoxic effect of the uncon-
jugated compound (Fig. S8, ESI†).
Overall, we describe a new strategy to target biomimetic silica
particles to the nucleus of eukaryotic cells without any detect-
able eﬀects on cell viability. Covalent conjugation of the bioac-
tive food constituent quercetin to a similarly safe silaﬃn-based
peptide that is used to generate biomimetic silica, provides an
almost ideal cellular shuttle. To attach cargo to this shuttle the
cysteine residue oﬀers itself as an attachment point that could
be used to release cargo via redox-mediated processes on its way
through the cytoplasm or via more stable linkages within the
nucleus.
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